Although the antiangiogenic mechanism mediated by the VEGF/VEGFR 2 pathway is one of the most important mechanisms [5,6], we should not omit that alternative proangiogenic pathways could be activated [6], especially in cancer and possibly in endometriosis and OA as an adaptive response. This evidence concerns the gene VEGFA and cancer.